BioCentury
ARTICLE | Company News

Therapade Technologies LLC, Tikvah Therapeutics deal

February 19, 2007 8:00 AM UTC

Therapade granted Tikvah exclusive worldwide rights to develop and commercialize D-cycloserine to treat anxiety-related disorders, including post-traumatic stress disorder, panic, social phobia and ob...